fda drug shortages semaglutide injection shortage resolved 2025 Novo's Wegovy and Ozempic removed from US list, compounders on notice Semaglutide shortage ends as FDA

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test analyzes key variants in GLP1R (rs6923761), GIPR (rs1800437), and FTO (rs9939609)regions that influence both metabolic response and cardiovascular adaptation to GLP-1 therapy

Patients should seek urgent medical advice if they experience severe abdominal pain (especially if radiating to the back), persistent vomiting, or signs of dehydration, as these may indicate pancreatitis or other serious complications

For example, people who have tachycardia caused by hyperthyroidism also can experience nervousness, insomnia, sweating, tremors and other symptoms related to high levels of thyroid hormones

Taking GLP-1s may be one of those decisions that people need to discuss and make with their doctor, knowing that taking the drug requires a long-term commitment, and it may not be the best fit for people who struggle with taking medication daily or weekly. Study conducted amidst a spike in weight loss medication market GLP-1s have surged in popularity with approximately 1 in 8 adults in the United States saying they have used them for weight loss

So far, there have been no trials, verdicts or settlements